Endothelin-1 (ET-1) is a vasoactive peptide that is released by endothelial cells. This study was performed to determine whether vascular responses to ET-1 are altered by atherosclerosis. ET-1 (1 or 10 nmol) was injected intra-arterially into the perfused hind limb of normal cynomolgus monkeys and monkeys fed an atherogenic diet for 19 months. We calculated the resistance of the total limb and large arteries and estimated the resistance of the small vessels. The major finding was that ET-1 had minimal effects on large arteries in normal monkeys but produced pronounced constriction of large arteries in atherosclerotic monkeys. In both groups, ET-1 produced dilatation of small vessels at 1 nmol and constriction at 10 nmol. Indomethacin (6 mg/kg intravenously) did not affect the responses to ET-1 in normal or atherosclerotic monkeys. In summary, the major finding is that the constrictor responses of large arteries to ET-1 are potentiated by atherosclerosis. (Arteriosclerosis 10:1113-1118, November/December 1990) V asospasm or increased vasoconstriction is an important complication of atherosclerosis.1 Vasoconstrictor responses to several agonists are potentiated by atherosclerosis, 2 -7 probably due in part to impaired endotheliumdependent relaxation.58 - 12 The mechanisms by which atherosclerosis predisposes to vasospasm are not clear.Endothelium releases two types of relaxing factors, prostacyclin 13 and endothelium-derived relaxing factor (EDRF), 14 which modulate vascular responses to many vasoactive agents. In addition, the supernatants of endothelial cells in culture release a vasoconstrictor peptide, endothelin-1 (ET-1).15 -19 ET-1 is a potent mitogen in fibroblasts 20 and rat aortic smooth muscle cells, 21 which raises the possibility that ET-1 may play a role in the pathogenesis of atherosclerosis. 22 It is not known whether vascular responses to ET-1 are altered by atherosclerosis.In this study we tested the hypothesis that vasoconstrictor responses to ET-1 are altered by atherosclerosis. We also examined responses to ET-1 after administration of indomethacin to inhibit synthesis of prostacyclin and other vasodilator prostaglandins.
Methods AnimalsTwo groups of adult male Malaysian monkeys were studied. Nineteen normal monkeys were fed commercial laboratory chow (Purina Monkey Chow, Ralston Purina, Richmond, IN). Fourteen monkeys were fed the atherogenic diet, which contained cholesterol (1 mg/calorie) and fat (43% of total calories) for 19±0.5 (mean±SEM) months. The normal monkeys weighed 6.3±0.2 kg and the atherosclerotic monkeys weighed 5.6±0.3 kg. At intervals of 3 to 4 months, the monkeys were sedated with ketamine HCI (10 mg/kg intramuscularly), and a venous blood sample was obtained. Total cholesterol and triglyceride levels were determined with the method used by the Lipid Research Clinics Protocols for the AutoAnalyzer II (Technicon Instruments, Tarrytown, NY).
Hemodynamic StudiesAt the time of study, the monkeys were sedated with ketamine (15 mg/kg intramuscularly) and were anesthetized with chl...